What does HVR (high ventricular rate) × 27 mean on pacemaker interrogation?

HVR × 27 on Pacemaker Interrogation

HVR × 27 means the pacemaker has detected 27 separate episodes of high ventricular rate (ventricular rate exceeding a programmed threshold, typically ≥180 bpm), which requires immediate review of stored electrograms to determine if these represent true ventricular tachycardia, rapidly conducted atrial fibrillation/flutter, or device oversensing.

What This Finding Represents

Modern pacemakers automatically detect and log episodes when the sensed ventricular rate exceeds a programmed threshold (commonly 180 bpm or higher). The "× 27" indicates 27 distinct episodes have been recorded since the last interrogation or counter reset 1.

These episodes could represent:

• Atrial fibrillation with rapid ventricular response (most common, ~50% of cases) 2
• Atrial flutter or atrial tachycardia with rapid conduction (~47% of cases) 2
• True ventricular tachycardia (uncommon, ~3% of cases) 2
• Device oversensing (noise, T-wave oversensing, lead malfunction)

Immediate Clinical Actions Required

You must review the stored electrograms from the device to classify these episodes. Without electrogram review, you cannot determine the clinical significance or appropriate management 2.

Step 1: Electrogram Analysis

• Access stored intracardiac electrograms for representative HVR episodes
• Determine atrial and ventricular relationship
• Classify as supraventricular (AF/flutter/AT) versus ventricular arrhythmia
• Rule out oversensing artifacts

Step 2: Assess Clinical Correlation

• Review symptoms: syncope, palpitations, dyspnea, chest pain during episode timestamps
• Check AF burden: Patients with HVR episodes typically have significantly higher atrial fibrillation burden (median 1.9 vs 0.2 hours/day) 2
• Evaluate for hemodynamic compromise

Prognostic Significance

The presence of HVR episodes identifies a high-risk patient subgroup requiring intensified monitoring and management 2.

Mortality Risk

• In heart failure patients with CRT-P devices, VHR episodes within the first year predict significantly higher 5-year mortality (77% vs 48%, HR 9.96) 3
• However, in standard pacemaker populations without heart failure, VHR episodes show no increased all-cause mortality on long-term follow-up 4

Cardiovascular Hospitalization Risk

After controlling for AF burden and heart disease, HVR episodes independently predict cardiovascular hospitalization (OR 2.92,95% CI 1.33-6.38) 2.

Stroke Risk Considerations

While the evidence provided focuses on atrial high-rate episodes rather than ventricular, rapid ventricular rates during atrial arrhythmias warrant stroke risk assessment using CHA₂DS₂-VASc scoring and consideration of anticoagulation 1.

Management Algorithm

If electrograms confirm rapid AF/flutter:

1. Assess CHA₂DS₂-VASc score for anticoagulation indication
2. Optimize rate control medications (beta-blockers, calcium channel blockers, digoxin)
3. Consider rhythm control strategy if symptomatic
4. Reprogram device to optimize AV node management if applicable

If electrograms confirm ventricular tachycardia:

1. Urgent cardiology/electrophysiology consultation
2. Assess for structural heart disease and ischemia
3. Consider ICD upgrade if sustained VT and meaningful survival >1 year expected
4. Initiate antiarrhythmic therapy as appropriate

If electrograms show oversensing:

1. Reprogram sensing parameters
2. Evaluate lead integrity
3. Adjust blanking periods if necessary 5

Common Pitfalls to Avoid

• Never assume HVR episodes are benign without electrogram review - 3% represent true VT 2
• Don't confuse with atrial high-rate episodes (AHRE) - these are distinct diagnostic categories with different thresholds and implications 1
• Beware of device misclassification - atrial events can be misinterpreted as ventricular if they fall within post-ventricular atrial blanking periods 5
• Monitor for improvement - HVR episode frequency typically decreases with optimized rate control over time 2

Follow-Up Monitoring

Establish more frequent device interrogations (every 3 months initially) for patients with documented HVR episodes to assess:

• Episode frequency trends
• Adequacy of rate/rhythm control
• Need for therapy escalation
• Development of symptoms